ANDRÉS CANUT BLASCO-rekin lankidetzan egindako argitalpenak (8)
2024
-
Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 885-893
-
Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach
Antibiotics, Vol. 13, Núm. 6
2023
-
Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study
Blood Purification, Vol. 52, Núm. 5, pp. 464-473
2021
-
High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?
Journal of Infection
-
Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis
Pharmaceutics, Vol. 13, Núm. 11
-
Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies
Pharmaceutics, Vol. 13, Núm. 7
2019
-
Antibiotic susceptibility trend before and after long-term use of selective digestive decontamination: a 16 year ecological study
The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 8, pp. 2289-2294
-
Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment
Journal of Critical Care, Vol. 50, pp. 69-76